SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Amgen Says Serious Adverse Events Were Balanced Across Treatment Groups

Serious adverse events and discontinuations were balanced across all treatment groups.

AMGN

Related stories